Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA

OBJECTIVE: To examine disease activity and clinical outcomes, and describe overall patterns of systemic lupus erythematosus (SLE) care in patients who received belimumab in a real-world clinical setting. METHODS: This observational cohort study was conducted in US clinical practices. Rheumatologists...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, C E, Dall'Era, M, Kan, H, Macahilig, C, Molta, C, Koscielny, V, Chang, D J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical Trials and Drug Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716417/
https://www.ncbi.nlm.nih.gov/pubmed/26835146
http://dx.doi.org/10.1136/lupus-2015-000118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716417/
https://www.ncbi.nlm.nih.gov/pubmed/26835146
http://dx.doi.org/10.1136/lupus-2015-000118

Ejemplares similares